Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders

다국어 초록 (Multilingual Abstract)

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social and communication impairments, as well as repetitive and restrictive behaviors. The phenotypic heterogeneity of ASD has made it overwhelmingly difficult to determine the exact etiology and pathophysiology underlying the core symptoms, which are often accompanied by comorbidities such as hyperactivity, seizures, and sensorimotor abnormalities. To our benefit, the advent of animal models has allowed us to assess and test diverse risk factors of ASD, both genetic and environmental, and measure their contribution to the manifestation of autistic symptoms. At a broader scale, rodent models have helped consolidate molecular pathways and unify the neurophysiological mechanisms underlying each one of the various etiologies. This approach will potentially enable the stratification of ASD into clinical, molecular, and neurophenotypic subgroups, further proving their translational utility. It is henceforth paramount to establish a common ground of mechanistic theories from complementing results in preclinical research. In this review, we cluster the ASD animal models into lesion and genetic models and further classify them based on the corresponding environmental, epigenetic and genetic factors. Finally, we summarize the symptoms and neuropathological highlights for each model and make critical comparisons that elucidate their clinical and neurobiological relevance.

참고문헌 (Reference)

• 1 Rout, U. K, "pathogenetic model of autism involving Purkinje cell loss through anti-GAD antibodies" 71 : 218-221, 2008
• 2 Papaleo, F, "Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice" 18 : 534-544, 2011
• 3 Tavassoli, T, "Variation in the autism candidate gene GABRB3modulates tactile sensitivity in typically developing children" 3 : 6-, 2012
• 4 Kumamaru, E, "Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons" 569 : 142-147, 2014
• 5 Fukuchi, M, "Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions" 65 : 35-43, 2009
• 6 Jung, G. A, "Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway" 9 : 66-, 2008
• 7 Cho, K. S, "Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modula-tion of tPA/PAI-1 activity" 61 : 694-709, 2013
• 8 Ornoy, A, "Valproic acid in pregnancy: how much are we endangering the embryo and fetus?" 28 : 1-10, 2009
• 9 Rutter, M, "Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies" 44 : 1092-1115, 2003
• 10 Jung, K. -M, "Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome" 3 : 1080-, 2012
• 11 Onda, H, "Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway" 21 : 561-574, 2002
• 12 Schaaf, C. P, "Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism" 45 : 1405-1408, 2013
• 13 Arndt, T. L, "The teratology of autism" 23 : 189-199, 2005
• 14 Chahrour, M, "The story of Rett syndrome:from clinic to neurobiology" 56 : 422-437, 2007
• 15 Winslow, J. T, "The social deficits of the oxytocin knockout mouse" 36 : 221-229, 2002
• 16 Caldwell, H. K, "The role of the vasopressin 1b receptor in aggression and other social behaviours" 170 : 65-72, 2008
• 17 Bernard, S, "The role of mercury in the pathogenesis of autism" 7 (7): s42-s43, 2002
• 18 Spence, S. J, "The role of epilepsy and epileptiform EEGs in autism spectrum disorders" 65 : 599-606, 2009
• 19 D'Arcangelo, G, "The reeler mouse: anatomy of a mutant" 71 : 383-417, 2005
• 20 Hunter, P, "The psycho gene" 11 : 667-669, 2010
• 21 Tueting, P, "The phenotypic characteristics of heterozygous reeler mouse" 10 : 1329-1334, 1999
• 22 LoParo, D, "The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis" 20 : 640-646, 2015
• 23 Pardo, C. A, "The neurobiology of autism" 17 : 434-447, 2007
• 24 Kuemerle, B, "The mouse Engrailed genes: a window into autism" 176 : 121-132, 2007
• 25 Stanfield, B. B, "The morphology of the hippocampus and dentate gyrus in normal and reeler mice" 185 : 393-422, 1979
• 26 Bear, M. F, "The mGluR theory of fragile X mental retardation" 27 : 370-377, 2004
• 27 Boccaccio, I, "The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region" 8 : 2497-2505, 1999
• 28 Podhorna, J, "The heterozygous reeler mouse: behavioural phenotype" 153 : 43-54, 2004
• 29 Fombonne, E, "The epidemiology of autism: a review" 29 : 769-786, 1999
• 30 Goffinet, A. M, "The embryonic development of the inferior olivary complex in normal and reeler (rlORL) mutant mice" 219 : 10-24, 1983
• 31 Kim, K. C, "The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats" 201 : 137-142, 2011
• 32 Kemper, T. L, "The contribution of neuropathologic studies to the understanding of autism" 11 : 175-187, 1993
• 33 Insel, T. R, "The challenge of translation in social neuroscience:a review of oxytocin, vasopressin, and affiliative behavior" 65 : 768-779, 2010
• 34 Gardiner, S. M, "The cardiovascular and renal responses to short-term isolation in Brattleboro rats" 64 : 377-382, 1983
• 35 Schumann, C. M, "The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages" 24 : 6392-6401, 2004
• 36 Amaral, D, "The amygdala and autism: implications from non-human primate studies" 2 : 295-302, 2003
• 37 Bielsky, I. F, "The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study" 47 : 503-513, 2005
• 38 Guy, J, "The Role of MeCP2 in the Brain" 27 : 631-652, 2011
• 39 Wang, S. S, "The Cerebellum, Sensitive Periods, and Autism" 83 : 518-532, 2014
• 40 Hertz-Picciotto, I, "The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism" 114 : 1119-1125, 2006
• 41 Comoletti, D, "The Arg451Cysneuroligin-3 mutation associated with autism reveals a defect in protein processing" 24 : 4889-4893, 2004
• 42 Greer, P. L, "The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc" 140 : 704-716, 2010
• 43 Manning, M. A, "Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum" 114 : 451-457, 2004
• 44 Busquets-Garcia, A, "Targeting the endocannabinoid system in the treatment of fragile X syndrome" 19 : 603-607, 2013
• 45 Benvenuto, A, "Syndromic autism: causes and pathogenetic pathways" 5 : 169-176, 2009
• 46 Walcott, E. C, "Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero" 31 : 13097-13109, 2011
• 47 Wahlsten, D, "Survey of 21 inbred mouse strains in two laboratories reveals that BTBR T/+ tf/tf has severely reduced hippocampal commissure and absent corpus callosum" 971 : 47-54, 2003
• 48 Benayed, R, "Support for the homeobox transcription factor gene ENGRAILED 2as an autism spectrum disorder susceptibility locus" 77 : 851-868, 2005
• 49 Butler, M. G, "Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations" 42 : 318-321, 2005
• 50 Kim, J. W, "Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism" 9 : e104927-, 2014
• 51 Golan, H. M, "Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy" 48 : 903-917, 2005
• 52 Li, X, "Solution structure of GOPC PDZ domain and its interaction with the C-terminal motif of neuroligin" 15 : 2149-2158, 2006
• 53 Wersinger, S. R, "Social motivation is reduced in vasopressin 1b receptor null mice despite normal performance in an olfactory discrimination task" 46 : 638-645, 2004
• 54 Mineur, Y. S, "Social behavior deficits in the Fmr1 mutant mouse" 168 : 172-175, 2006
• 55 Moy, S. S, "Social approach in genetically engineered mouse lines relevant to autism" 8 : 129-142, 2009
• 56 Silverman, J. L, "Sociability and motor functions in Shank1 mutant mice" 1380 : 120-137, 2011
• 57 Hung, A. Y, "Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1" 28 : 1697-1708, 2008
• 58 Schreck, K. A, "Sleep problems as possible predictors of intensified symptoms of autism" 25 : 57-66, 2004
• 59 Nussbaum, J, "Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers" 17 : 1569-1577, 2008
• 60 Peca, J, "Shank3 mutant mice display autistic-like behaviours and striatal dysfunction" 472 : 437-442, 2011
• 61 Rios, M, "Severe deficits in 5-HT2A -mediated neurotransmission in BDNF conditional mutant mice" 66 : 408-420, 2006
• 62 Betancur, C, "Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder" 7 : 67-71, 2002
• 63 Daws, L. C, "Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice" 101 : 641-651, 2007
• 64 Lozovaya, N, "Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model" 5 : 4563-, 2014
• 65 Volkmar, F. R, "Seizure Disorders in Autism" 29 : 127-129, 1990
• 66 Meyer, U, "Schizophrenia and autism:both shared and disorder-specific pathogenesis via perinatal inflammation?" 69 : 26r-33r, 2011
• 67 Sato, D, "SHANK1 Deletions in Males with Autism Spectrum Disorder" 90 : 879-887, 2012
• 68 Guffanti, G, "Role of UBE3A and ATP10A genes in autism susceptibility region 15q11-q13 in an Italian population: A positive replication for UBE3A" 185 : 33-38, 2011
• 69 Maezawa, I, "Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate" 30 : 5346-5356, 2010
• 70 Amir, R. E, "Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2" 23 : 185-188, 1999
• 71 Silverman, J. L, "Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP" 35 : 976-989, 2010
• 72 Martin, L. A, "Repetitive behavior and increased activity in mice with Purkinje cell loss: a model for understanding the role of cerebellar pathology in autism" 31 : 544-555, 2010
• 73 Iafrati, J, "Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway" 19 : 417-426, 2014
• 74 Rogers, J. T, "Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density" 18 : 558-564, 2011
• 75 Chen, Y, "Reelin modulates NMDA receptor activity in cortical neurons" 25 : 8209-8216, 2005
• 76 Yip, J. W, "Reelin controls position of autonomic neurons in the spinal cord" 97 : 8612-8616, 2000
• 77 Patrylo, P. R, "Reeler homozygous mice exhibit enhanced susceptibility to epileptiform activity" 47 : 257-266, 2006
• 78 Scattoni, M. L, "Reduced ultrasonic vocalizations in vasopressin 1b knockout mice" 187 : 371-378, 2008
• 79 Jamain, S, "Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism" 105 : 1710-1715, 2008
• 80 Wohr, M, "Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of autism" 10 : 35-43, 2011
• 81 Yang, M, "Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3null mutant mice" 32 : 6525-6541, 2012
• 82 Dani, V. S, "Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome" 102 : 12560-12565, 2005
• 83 Oblak, A. L, "Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism" 1380 : 218-228, 2011
• 84 Strauss, K. A, "Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2" 354 : 1370-1377, 2006
• 85 Walsh, T, "Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia" 320 : 539-543, 2008
• 86 The International Schizophrenia Consortium, "Rare chromosomal deletions and duplications increase risk of schizophrenia" 455 : 237-241, 2008
• 87 Kwon, C. H, "Pten regulates neuronal arborization and social interaction in mice" 50 : 377-388, 2006
• 88 Luikart, B. W, "Pten knockdown in vivo increases excitatory drive onto dentate granule cells" 31 : 4345-4354, 2011
• 89 Di Cristofano, A, "Pten is essential for embryonic development and tumour suppression" 19 : 348-355, 1998
• 90 Gregorian, C, "Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis" 29 : 1874-1886, 2009
• 91 Husi, H, "Proteomic analysis of NMDA receptor-adhesion protein signaling complexes" 3 : 661-669, 2000
• 92 Andari, E, "Promoting social behavior with oxytocin in highfunctioning autism spectrum disorders" 107 : 4389-4394, 2010
• 93 Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators, "Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2010" 63 : 1-21, 2010
• 94 Go, H. S, "Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway" 63 : 1028-1041, 2012
• 95 Kolevzon, A, "Prenatal and perinatal risk factors for autism: a review and integration of findings" 161 : 326-333, 2007
• 96 Dykens, E. M, "Prader-Willi syndrome and autism spectrum disorders: an evolving story" 3 : 225-237, 2011
• 97 Savaskan, E, "Post-learning intranasal oxytocin modulates human memory for facial identity" 33 : 368-374, 2008
• 98 Yamashita, Y, "Possible association between congenital cytomegalovirus infection and autistic disorder" 33 : 455-459, 2003
• 99 Wu, S, "Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population" 58 : 74-77, 2005
• 100 Parker, K. J, "Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder" 111 : 12258-12263, 2014
• 101 Aman, M. G, "Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders" 30 : 451-459, 2000
• 102 Sala, M, "Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice:a neurobehavioral model of autism" 69 : 875-882, 2011
• 103 Chakrabarti, S, "Pervasive developmental disorders in preschool children: confirmation of high prevalence" 162 : 1133-1141, 2005
• 104 MacQueen, G. M, "Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression" 115 : 1145-1153, 2001
• 105 Kim, K. C, "Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offsprin" 49 : 512-528, 2014
• 106 Kuemerle, B, "Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development" 17 : 7881-7889, 1997
• 107 Daniels, J. L, "Parental psychiatric disorders associated with autism spectrum disorders in the offspring" 121 : E1357-E1362, 2008
• 108 Rogers, S. J, "Parent reports of sensory symptoms in toddlers with autism and those with other developmental disorders" 33 : 631-642, 2003
• 109 Zhou, J, "PTEN signaling in autism spectrum disorders" 22 : 873-879, 2012
• 110 Chu, E. C, "PTEN regulatory functions in tumor suppression and cell biology" 10 : RA235-RA241, 2004
• 111 Tyzio, R, "Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring" 343 : 675-679, 2014
• 112 Pobbe, R. L, "Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors" 61 : 436-444, 2012
• 113 Tansey, K. E, "Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: genetic and molecular studies" 474 : 163-167, 2010
• 114 Hollander, E, "Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders" 28 : 193-198, 2003
• 115 Guastella, A. J, "Oxytocin increases gaze to the eye region of human faces" 63 : 3-5, 2008
• 116 Ferguson, J. N, "Oxytocin in the medial amygdala is essential for social recognition in the mouse" 21 : 8278-8285, 2001
• 117 Rett, A, "On a unusual brain atrophy syndrome in hyperammonemia in childhood" 116 : 723-726, 1966
• 118 Stromland, K, "Offspring of male and female parents with thalidomide embryopathy:birth defects and functional anomalies" 66 : 115-121, 2002
• 119 Kuwagata, M, "Observation of fetal brain in a rat valproate-induced autism model: a developmental neurotoxicity study" 27 : 399-405, 2009
• 120 Ballas, N, "Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology" 12 : 311-317, 2009
• 121 Zhong, H, "No association between the EN2 gene and autistic disorder" 40 : E4-, 2003
• 122 Huang, E. J, "Neurotrophins: roles in neuronal development and function" 24 : 677-736, 2001
• 123 Kemper, T. L, "Neuropathology of infantile autism" 57 : 645-652, 1998
• 124 Carson, R. P, "Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin" 45 : 369-380, 2012
• 125 Sudhof, T. C, "Neuroligins and neurexins link synaptic function to cognitive disease" 455 : 903-911, 2008
• 126 Radyushkin, K, "Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit" 8 : 416-425, 2009
• 127 Blundell, J, "Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior" 30 : 215-2129, 2010
• 128 Lush, M. E, "Neurofibromin is required for barrel formation in the mouse somatosensory cortex" 28 : 1580-1587, 2008
• 129 Yamauchi, J, "Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin" 314 : 2279-2288, 2008
• 130 Ognibene, E, "Neurobehavioural disorders in the infant reeler mouse model: interaction of genetic vulnerability and consequences of maternal separation" 177 : 142-149, 2007
• 131 Romero, E, "Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics" 32 : 1791-1804, 2007
• 132 Miura, K, "Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice" 9 : 149-159, 2002
• 133 Bolton, P. F, "Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex" 125 : 1247-1255, 2002
• 134 Choquet, D, "NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin" 27 : 10165-10175, 2007
• 135 Gauthier, J, "NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population" 132b : 74-75, 2005
• 136 Cichowski, K, "NF1 tumor suppressor gene function:narrowing the GAP" 104 : 593-604, 2001
• 137 Rasmussen, S. A, "NF1 gene and neurofibromatosis 1" 151 : 33-40, 2000
• 138 Jamain, S, "Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism" 34 : 27-29, 2003
• 139 Durand, C. M, "Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders" 39 : 25-27, 2007
• 140 Berkel, S, "Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation" 42 : 489-491, 2010
• 141 Auerbach, B. D, "Mutations causing syndromic autism define an axis of synaptic pathophysiology" 480 : 63-68,
• 142 Hoeffer, C. A, "Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation" 109 : 68-76, 2013
• 143 Etherton, M. R, "Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments" 106 : 17998-18003, 2009
• 144 Sinkkonen, S. T, "Mouse models of Angelman syndrome, a neurodevelopmental disorder, display different brain regional GABA(A) receptor alterations" 340 : 205-208, 2003
• 145 Martin, M. R, "Morphology of the cochlear nucleus of the normal and reeler mutant mouse" 197 : 141-152, 1981
• 146 Bortolato, M, "Monoamine oxidase A and A/B knockout mice display autistic-like features" 16 : 869-888, 2013
• 147 Veenstra-Vanderweele, J, "Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse" 1 : 158-171, 2009
• 148 Hsiao, E. Y, "Modeling an autism risk factor in mice leads to permanent immune dysregulation" 109 : 12776-12781, 2012
• 149 Jiang, Y. H, "Modeling Autism by SHANK Gene Mutations in Mice" 78 : 8-27, 2013
• 150 Casanova, M. F, "Minicolumnar abnormalities in autism" 112 : 287-303, 2006
• 151 Singh, N. N, "Mindful parenting decreases aggression, noncompliance, and self-injury in children with autism" 14 : 169-177, 2006
• 152 Engelmann, M, "Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats" 22 : 145-149, 1994
• 153 Weidner, K. L, "Mice over-expressing BDNF in forebrain neurons develop an altered behavioral phenotype with age" 268 : 222-228, 2014
• 154 Holmes, A, "Mice lacking the serotonin transporter exhibit 5-HT(1A)receptor-mediated abnormalities in tests for anxiety-like behavior" 28 : 2077-2088, 2003
• 155 DeLorey, T. M, "Mice lacking the beta3subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome" 18 : 8505-8514, 1998
• 156 Homanics, G. E, "Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior" 94 : 4143-4148, 1997
• 157 Abraham, W. C, "Metaplasticity: tuning synapses and networks for plasticity" 9 : 387-, 2008
• 158 Nosyreva, E. D, "Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome" 95 : 3291-3295, 2006
• 159 Bachevalier, J, "Medial temporal lobe structures and autism: a review of clinical and experimental findings" 32 : 627-648, 1994
• 160 Costa, R. M, "Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1" 415 : 526-530, 2002
• 161 Chahrour, M, "MeCP2, a key contributor to neurological disease, activates and represses transcription" 320 : 1224-1229, 2008
• 162 Kim, K. C, "MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism" 1-17, 2014
• 163 Patterson, P. H, "Maternal infection and immune involvement in autism" 17 : 389-394, 2011
• 164 Smith, S. E, "Maternal immune activation alters fetal brain development through interleukin-6" 27 : 10695-10702, 2007
• 165 Croen, L. A, "Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr" 159 : 151-157, 2005
• 166 Hazlett, H. C, "Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years" 62 : 1366-1376, 2005
• 167 Fidler, D. J, "Macrocephaly in autism and other pervasive developmental disorders" 42 : 737-740, 2000
• 168 Reith, R. M, "Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration" 43 : 113-122, 2011
• 169 Tang, G, "Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits" 83 : 1131-1143, 2014
• 170 Bateup, H. S, "Loss of Tsc1 in vivo impairs hippocampal mGluRLTD and increases excitatory synaptic function" 31 : 8862-8869, 2011
• 171 Carper, R. A, "Localized enlargement of the frontal cortex in early autism" 57 : 126-133, 2005
• 172 Wagstaff, J, "Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chromosome 15" 49 : 330-337, 1991
• 173 Kim, H. J, "Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides" 75 : 1021-1030, 2009
• 174 Alarcón, M, "Linkage, Association, and Gene-Expression Analyses Identify CNTNAP2 as an Autism-Susceptibility Gene" 82 : 150-159, 2008
• 175 Costa, R. M, "Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1" 27 : 399-405, 2001
• 176 Moretti, P, "Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome" 26 : 319-327, 2006
• 177 Martin, H. G, "Late onset deficits in synaptic plasticity in the valproic acid rat model of autism" 8 : 23-, 2014
• 178 Lante, F, "Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation" 18 : 602-609, 2008
• 179 Tsai, S. J, "Is autism caused by early hyperactivity of brain-derived neurotrophic factor?" 65 : 79-82, 2005
• 180 Guastella, A. J, "Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders" 67 : 692-694, 2010
• 181 Yasui, D. H, "Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes" 104 : 19416-19421, 2007
• 182 Berkel, S, "Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology" 21 : 344-357, 2012
• 183 Szatmari, P, "Informative phenotypes for genetic studies of psychiatric disorders" 144b : 581-588, 2007
• 184 Shinohe, A, "Increased serum levels of glutamate in adult patients with autism" 30 : 1472-1477, 2006
• 185 Smith, S. E, "Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice" 3 : 103RA97-, 2011
• 186 Hutsler, J. J, "Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders" 1309 : 83-94, 2010
• 187 Bonaguidi, M. A, "In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics" 145 : 1142-1155, 2011
• 188 Nakao, M, "Imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D15S225E)" 3 : 309-315, 1994
• 189 Verpelli, C, "Importance of Shank3protein in regulating metabotropic glutamate receptor 5 (mGluR5)expression and signaling at synapses" 286 : 34839-34850, 2011
• 190 Chevere-Torres, I, "Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin" 45 : 156-164, 2012
• 191 Jiang, X, "Impaired hypothalamicpituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice" 34 : 317-331, 2009
• 192 Kavaliers, M, "Impaired discrimination of and aversion to parasitized male odors by female oxytocin knockout mice" 2 : 220-230, 2003
• 193 Schmale, H, "Impact of altered protein structures on the intracellular traffic of a mutated vasopressin precursor from Brattleboro rats" 182 : 621-627, 1989
• 194 Skidmore, B. J, "Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities" 114 : 770-775, 1975
• 195 Patterson, P. H, "Immune involvement in schizophrenia and autism: etiology, pathology and animal models" 204 : 313-321, 2009
• 196 Numis, A, "Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex" 76 : 981-987, 2011
• 197 Kalueff, A. V, "Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice" 6 : 389-400, 2007
• 198 Hranilovic, D, "Hyperserotonemia in autism: the potential role of 5HT-related gene variants" 32 (32): 75-80, 2008
• 199 Rinaldi, T, "Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic Acid animal model of autism" 2 : 4-, 2008
• 200 Turrigiano, G, "Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function" 4 : a005736-, 2012
• 201 Stephenson, D. T, "Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis" 2 : 7-, 2011
• 202 Bauman, M, "Histoanatomic observations of the brain in early infantile autism" 35 : 866-874, 1985
• 203 Brune, C. W, "Heterogeneous association between engrailed-2 and autism in the CPEA network" 147 : 187-193, 2008
• 204 Gillberg, C, "Head circumference in autism, Asperger syndrome, and ADHD: a comparative study" 44 : 296-300, 2002
• 205 Bozdagi, O, "Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication" 1 : 15-, 2010
• 206 Fatemi, S. H, "Glutamic acid decarboxylase 65 and 67kDa proteins are reduced in autistic parietal and cerebellar cortices" 52 : 805-810, 2002
• 207 Ehninger, D, "Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice" 17 : 62-70, 2012
• 208 Gregory, S. G, "Genomic and epigenetic evidence for oxytocin receptor deficiency in autism" 7 : 62-, 2009
• 209 Geschwind, D. H, "Genetics of autism spectrum disorders" 15 : 409-416, 2011
• 210 Warrier, V, "Genetic variation in GABRB3 is associated with Asperger syndrome and multiple endophenotypes relevant to autism" 4 : 48-, 2013
• 211 Leblond, C. S, "Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders" 8 : E1002521-, 2012
• 212 Bill, B. R, "Genetic advances in autism:heterogeneity and convergence on shared pathways" 19 : 271-278, 2009
• 213 Hallmayer, J, "Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism" 68 : 1095-1102, 2011
• 214 Schneider, T, "Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid" 33 : 728-740, 2008
• 215 DeLorey, T. M, "Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder" 187 : 207-220, 2008
• 216 Blatt, G. J, "GABAergic cerebellar system in autism: a neuropathological and developmental perspective" 71 : 167-178, 2005
• 217 Fatemi, S. H, "GABA(A) receptor downregulation in brains of subjects with autism" 39 : 223-230, 2009
• 218 Garber, K. B, "Fragile X syndrome" 16 : 666-672, 2008
• 219 Weiler, I. J, "Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation" 94 : 5395-5400, 1997
• 220 Brennan, F. X, "Fmr1 knockout mice are impaired in a leverpress escape/avoidance task. Genes Brain Behav" 5 : 467-471, 2006
• 221 Bernardet, M, "Fmr1 KO mice as a possible model of autistic features" 6 : 1164-1176, 2006
• 222 Chadman, K. K, "Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism" 97 : 586-594, 2011
• 223 Christianson, A. L, "Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs" 36 : 361-369, 1994
• 224 Martins, Y, "Feeding and eating behaviors in children with autism and typically developing children" 38 : 1878-1887, 2008
• 225 Fisher, S. E, "FOXP2 as a molecular window into speech and language" 25 : 166-177, 2009
• 226 Zec, N, "Expression of the homeobox-containing genes EN1 and EN2 in hu-man fetal midgestational medulla and cerebellum" 56 : 236-242, 1997
• 227 Smalheiser, N. R, "Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells" 97 : 1281-1286, 2000
• 228 Peñagarikano, O, "Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism" 7 : 271ra8-, 2015
• 229 Chan, J. P, "Examination of behavioral deficits triggered by targeting Bdnf in fetal or postnatal brains of mice" 142 : 49-58, 2006
• 230 Wassink, T. H, "Examination of AVPR1a as an autism susceptibility gene" 9 : 968-972, 2004
• 231 Santini, E, "Exaggerated translation causes synaptic and behavioural aberrations associated with autism" 493 : 411-415, 2013
• 232 McNaughton, C. H, "Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome" 122 : 293-300, 2008
• 233 Pierce, K, "Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism" 49 : 655-664, 2001
• 234 Mazina, V, "Epigenetics of autism-related impairment: copy number variation and maternal infection" 36 : 61-67, 2015
• 235 Samaco, R. C, "Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3" 14 : 483-492, 2005
• 236 Prasad, H. C, "Enhanced activity of human serotonin transporter variants associated with autism" 364 : 163-173, 2009
• 237 Kano, M, "Endocannabinoid-mediated control of synaptic transmission" 309-380, 2009
• 238 Cheh, M. A, "En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder" 1116 : 166-176, 2006
• 239 Ashwood, P, "Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome" 25 : 40-45, 2011
• 240 Tottenham, N, "Elevated amygdala response to faces and gaze aversion in autism spectrum disorder" 9 : 106-117, 2014
• 241 Rinaldi, T, "Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid" 104 : 13501-13506, 2007
• 242 Muroga, T, "Effects of thyrotropin releasing hormone on cerebellar mutant mice--a kinesiological comparison between rolling mouse Nagoya, weaver and reeler" 21 : 101-108, 1982
• 243 Joyal, C. C, "Effects of midline and lateral cerebellar lesions on motor coordination and spatial orientation" 739 : 1-11, 1996
• 244 Bobee, S, "Effects of early midline cerebellar lesion on cognitive and emotional functions in the rat" 112 : 107-117, 2000
• 245 Wolterink, G, "Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders" 11 : 51-59, 2001
• 246 Diergaarde, L, "Early amygdala damage disrupts performance on medial prefrontal cortex-related tasks but spares spatial learning and memory in the rat" 130 : 581-590, 2005
• 247 Jyonouchi, H, "Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention" 51 : 77-85, 2005
• 248 Chao, H. T, "Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes" 468 : 263-269, 2010
• 249 Liu, W. S, "Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse" 98 : 3477-3482, 2001
• 250 Liu, Z. H, "Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome" 454 : 62-66, 2009
• 251 Casanova, M. F, "Disruption in the inhibitory architecture of the cell minicolumn: implications for autisim" 9 : 496-507, 2003
• 252 Allen, G, "Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism" 160 : 262-273, 2003
• 253 Amodeo, D. A, "Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors" 227 : 64-72, 2012
• 254 Eslinger, P. J, "Developmental outcomes after early prefrontal cortex damage" 55 (55): 2004
• 255 Pletnikov, M. V, "Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism" 100 : 43-50, 1999
• 256 Correa-Cerro, L. S, "Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy" 15 : 839-851, 2006
• 257 Strang, J. F, "Depression and Anxiety Symptoms in Children and Adolescents with Autism Spectrum Disorders without Intellectual Disability" 6 : 406-412, 2012
• 258 Blatt, G. J, "Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study" 31 : 537-543, 2001
• 259 Irwin, S. A, "Dendritic spine structural anomalies in fragile-X mental retardation syndrome" 10 : 1038-1044, 2000
• 260 Ching, M. S, "Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders" 153 : 937-947, 2010
• 261 Sampath, S, "Defining the Contribution of CNTNAP2to Autism Susceptibility" 8 : 77906-, 2013
• 262 Schneider, M, "Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment" 30 : 944-957, 2005
• 263 Irons, M, "Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome" 341 : 1414-, 1993
• 264 Gauthier, J, "De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia" 107 : 7863-7868, 2010
• 265 Frye, C. A, "Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice" 100 : 264-267, 2010
• 266 Davis, L. K, "Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene" 147 : 1145-1151, 2008
• 267 Fatemi, S. H, "Consensus paper: pathological role of the cerebellum in autism" 11 : 777-807, 2012
• 268 Leyfer, O. T, "Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders" 36 : 849-861, 2006
• 269 Wohr, M, "Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior" 6 : e20631-, 2011
• 270 Goorden, S. M, "Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures" 62 : 648-655, 2007
• 271 Singh, C, "Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice" 110 : 12816-12821, 2013
• 272 Casanova, M. F, "Clinical and macroscopic correlates of minicolumnar pathology in autism" 17 : 692-695, 2002
• 273 Gillberg, C, "Chromosomal disorders and autism" 28 : 415-425, 1998
• 274 Perry, E. K, "Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain" 158 : 1058-1066, 2001
• 275 Yan, W. L, "Childhood-onset schizophrenia/autistic disorder and t(1;7)reciprocal translocation: identification of a BAC contig spanning the translocation breakpoint at 7q21" 96 : 749-753, 2000
• 276 Verheij, C, "Characterization and localization of the FMR-1 gene product associated with fragile X syndrome" 363 : 722-724, 1993
• 277 Poliak, S, "Caspr2, a New Member of the Neurexin Superfamily, Is Localized at the Juxtaparanodes of Myelinated Axons and Associates with K+ Channels" 24 : 1037-1047, 1999
• 278 Whitehouse, A. J, "CNTNAP2 variants affect early language development in the general population" 10 : 451-456, 2011
• 279 Murer, M. G, "Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease" 63 : 71-124, 2001
• 280 Monteggia, L. M, "Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors" 61 : 187-197, 2007
• 281 Binder, D. K, "Brain-derived neurotrophic factor" 22 : 123-131, 2004
• 282 Hardan, A. Y, "Brain volume in autism. J. Child Neurol" 16 : 421-424, 2001
• 283 Bryn, V, "Brain derived neurotrophic factor (BDNF)and autism spectrum disorders (ASD) in childhood" 19 : 411-414, 2015
• 284 DiMario, F. J., Jr, "Brain abnormalities in tuberous sclerosis complex" 19 : 650-657, 2004
• 285 Pletnikov, M. V, "Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders" 7 : d593-d607, 2002
• 286 Richt, J. A, "Borna disease virus infection in animals and humans" 3 : 343-352, 1997
• 287 Taieb, O, "Borna disease virus and psychiatry" 16 : 3-10, 2001
• 288 Lee, H. J, "Behavioural studies using temporal and spatial inactivation of the oxytocin receptor" 170 : 73-77, 2008
• 289 Salinger, W. L, "Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation" 117 : 1257-1275, 2003
• 290 Tierney, E, "Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome" 6 : 131-134, 2000
• 291 Chess, S, "Behavioral consequences of congenital rubella" 93 : 699-703, 1978
• 292 Korade, Z, "Behavioral and serotonergic response changes in the Dhcr7-HET mouse model of Smith-Lemli-Opitz syndrome" 106 : 101-108, 2013
• 293 Dufour-Rainfray, D, "Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism" 470 : 55-59, 2010
• 294 Larimore, J. L, "Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations" 34 : 199-211, 2009
• 295 Blanchard, D. C, "BTBR T+tf/J mice:autism-relevant behaviors and reduced fractone-associated heparan sulfate" 36 : 285-296, 2012
• 296 Won, H, "Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function" 486 : 261-265, 2012
• 297 Schmeisser, M. J, "Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2" 486 : 256-260, 2012
• 298 Tsai, P. T, "Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice" 488 : 647-651, 2012
• 299 Hatton, D. D, "Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP" 140A : 1804-1813, 2006
• 300 Gepner, B, "Autism: a world changing too fast for a mis-wired brain?" 33 : 1227-1242, 2009
• 301 Gkogkas, C. G, "Autism-related deficits via dysregulated eIF4Edependent translational control" 493 : 371-377, 2013
• 302 Etherton, M, "Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function" 108 : 13764-13769, 2011
• 303 Kataoka, S., "Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid" 16 : 91-103, 2013
• 304 McFarlane, H. G, "Autism-like behavioral phenotypes in BTBR T+tf/J mice" 7 : 152-163, 2008
• 305 Geschwind, D. H, "Autism spectrum disorders: developmental disconnection syndromes" 17 : 103-111, 2007
• 306 Cohen, I, "Autism severity is associated with child and maternal MAOA genotypes" 79 : 355-362, 2011
• 307 Curatolo, P, "Autism in tuberous sclerosis" 8 : 327-332, 2004
• 308 Peters, S, "Autism in Angelman syndrome: implications for autism research" 66 : 530-536, 2004
• 309 Bailey, A, "Autism as a strongly genetic disorder:evidence from a British twin study" 25 : 63-77, 1995
• 310 Huang, C. H, "Autism and serotonin transporter gene polymorphisms: A systematic review and meta-analysis" 147B : 903-913, 2008
• 311 Bello, S. C, "Autism and environmental influences: review and commentary" 22 : 139-156, 2007
• 312 Truong, D. T, "Auditory processing and morphological anomalies in medial geniculate nucleus of Cntnap2 mutant mice" 129 : 731-743, 2015
• 313 Aronson, M, "Attention deficits and autistic spectrum problems in children exposed to alcohol during gestation: a follow-up study" 39 : 583-587, 1997
• 314 Uhlmann, E. J, "Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures" 52 : 285-296, 2002
• 315 Mbarek, O, "Association study of the NF1 gene and autistic disorder" 88 : 729-732, 1999
• 316 Jacob, S, "Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism" 417 : 6-9, 2007
• 317 Liu, X, "Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population" 55 : 137-141, 2010
• 318 Cohen, I. L, "Association of autism severity with a monoamine oxidase A functional polymorphism" 64 : 190-197, 2003
• 319 Marui, T, "Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population" 131b : 43-47, 2004
• 320 Yirmiya, N, "Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills" 11 : 488-494, 2006
• 321 Buxbaum, J. D, "Association between a GABRB3 polymorphism and autism" 7 : 311-316, 2002
• 322 Li, X, "Association analysis of CNTNAP2 polymorphisms with autism in the Chinese Han population" 20 : 113-117, 2010
• 323 Bolivar, V. J, "Assessing autism-like behavior in mice: variations in social interactions among inbred strains" 176 : 21-26, 2007
• 324 Naviaux, R. K, "Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model" 8 : E57380-, 2013
• 325 Ylisaukko-oja, T, "Analysis of four neuroligin genes as candidates for autism" 13 : 1285-1292, 2005
• 326 Willner, J. P, "Analysis of a purported SHANK3 mutation in a boy with autism: Clinical impact of rare variant research in neurodevelopmental disabilities" 1380 : 98-105, 2011
• 327 Hornig, M, "An infection-based model of neurodevelopmental damage" 96 : 12102-12107, 1999
• 328 Meziane, H, "An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism" 78 : 85-94, 2015
• 329 American Psychiatric Association, "American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition" American Psychiatric Publishing 2013
• 330 Young, D. M, "Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism" 107 : 11074-11079, 2010
• 331 Jiang, Y. H, "Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3" e12278-, 2010
• 332 Taurines, R, "Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder" 121 : 1117-1128, 2014
• 333 Altamura, C, "Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study" 17 : 1394-1401, 2007
• 334 Zhang, J, "Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models" 101 : 2572-2580, 2009
• 335 Scott-Van Zeeland, A. A, "Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2" 2 : 56RA80-, 2010
• 336 Marrone, M. C, "Altered cortico-striatal synaptic plasticity and related behavioural impairments in reeler mice" 24 : 2061-2070, 2006
• 337 Popova, N. K, "Altered behavior and alcohol tolerance in transgenic mice lacking MAO A: a comparison with effects of MAO A inhibitor clorgyline" 67 : 719-727, 2000
• 338 Spencer, C. M, "Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome" 4 : 420-430, 2005
• 339 Hava, G, "Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy" 48 : 162-168, 2006
• 340 Cases, O, "Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA" 268 : 1763-1766, 1995
• 341 Wang, H, "Age- and genderdependent impairments of neurobehaviors in mice whose mothers were exposed to lipopolysaccharide during pregnancy" 192 : 245-251, 2010
• 342 Lee, B. K, "Advancing parental age and autism:multifactorial pathways" 21 : 118-125, 2015
• 343 Silva, A. J, "Adult reversal of cognitive phenotypes in neurodevelopmental disorders" 1 : 150-157, 2009
• 344 Karvat, G, "Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism" 39 : 831-840, 2014
• 345 Peñagarikano, O, "Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related Deficits" 147 : 235-246, 2011
• 346 Courchesne, E, "Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism:identification of hypoplastic and hyperplastic subgroups with MR imaging" 162 : 123-130, 1994
• 347 Tierney, E, "Abnormalities of cholesterol metabolism in autism spectrum disorders" 141b : 666-668, 2006
• 348 Waage-Baudet, H, "Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome:implications for autism" 21 : 451-459, 2003
• 349 Maccarrone, M, "Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA" 35 : 1500-1509, 2010
• 350 Steffenburg, S, "A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden" 30 : 405-416, 1989
• 351 Schaller, F, "A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene" 19 : 4895-4905, 2010
• 352 Ogawa, S, "A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice" 1168 : 112-123, 2007
• 353 Martin, L. A, "A relationship between cerebellar Purkinje cells and spatial working memory demonstrated in a lurcher/chimera mouse model system" 3 : 158-166, 2004
• 354 Barnea-Goraly, N, "A preliminary longitudinal volumetric MRI study of amygdala and hippocampal volumes in autism" 48 : 124-128, 2014
• 355 Meikle, L, "A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival" 27 : 5546-5558, 2007
• 356 Silva, A. J, "A mouse model for the learning and memory deficits associated with neurofibromatosis type I" 15 : 281-284, 1997
• 357 Guy, J, "A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome" 27 : 322-326, 2001
• 358 Jiang, Y. H, "A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A" 131 : 1-10, 2004
• 359 Need, A. C, "A genome-wide investigation of SNPs and CNVs in schizophrenia" 5 : E1000373-, 2009
• 360 Arking, D. E, "A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism" 82 : 160-164, 2008
• 361 Moore, S. J, "A clinical study of 57 children with fetal anticonvulsant syndromes" 37 : 489-497, 2000
• 362 Fitzky, B. U, "7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome" 108 : 905-915, 2001